Apiam Animal Health Limited (ASX:AHX) MD Dr. Chris Richards speaks with Tim Mckinnon about the company's growth target of $300 Million by the end of 2024.
Apiam Animal Health Limited (ASX:AHX) would like to advise that the Company has today despatched its Retail Offer Document in respect of the 1 for 4.8 pro-rata non-renounceable entitlement offer announced on 26 May 2022.
Apiam Animal Health Limited (ASX:AHX) refers to its announcement of 19 May 2022 and confirms that it has completed the acquisition of the assets of Romsey Veterinary Service, effective 1 June 2022.
Institutional investors have seen the light by backing regional vet operator Apiam Animal Health Limited (ASX:AHX) to deliver on their ambitious regional expansion strategy.
Apiam Animal Health Limited (ASX:AHX) is pleased to announce it has successfully completed the institutional component of the accelerated entitlement offer (Institutional Entitlement Offer), as announced to the ASX on 26 May 2022.
Apiam Animal Health Limited (ASX:AHX) is pleased to announce the launch of a 1 for 4.8 pro-rata non-renounceable entitlement offer to Eligible Shareholders to raise up $20.25 million before costs.
Apiam Animal Health Limited (ASX:AHX) is pleased to announce it has entered into binding agreements to acquire the assets of Victorian Equine Group and Romsey Veterinary Surgery.
